PapersPMID:40647269
Twelve-Week Curcumin Supplementation Improves Glucose Homeostasis and Gut Health in Prediabetic Older Adults: A Pilot, Double-Blind, Placebo-Controlled Trial.
No finding here moved its endpoint.
What did not
1 findingHow to read these marks →- No detected effect on fasting blood glucose
moderatereplicated ×2
“In contrast, the fasting blood glucose levels remained the same in both the curcumin ( p = 0.154, 95% CI: −7.547 to 0.976) and placebo group ( p > 0.999, 95% CI: −5.537 to 5.093).”
- Study
- RCT
- Duration
- 3 months
- Dose studied
- 80 mg curcumin (Longvida lipophilic matrix), one capsule daily
- Population
- adults aged 60 years or older with prediabetes or overweight/obesity; co-primary endpoint
Study record
- Design
- randomised controlled trial
- Species
- human
- Population
- Older adults (60 years or older) with prediabetes or overweight/obesity; curcumin 80 mg capsules
- Participants
- 28
- Comparator
- placebo
- Duration
- 84 days
- Endpoints measured
- 7
- Declined
- another reason, stated per paper
curcumin